spike
protein
sever
acut
respiratori
syndrom
coronaviru
sarscov
mediat
viral
entri
target
cell
cleavag
activ
sar
host
cell
proteas
essenti
infecti
viral
entri
respons
enzym
potenti
target
antivir
intervent
type
ii
transmembran
serin
proteas
cleav
activ
sar
cell
cultur
potenti
also
infect
host
investig
determin
sar
control
cleavag
activ
found
sar
residu
previous
identifi
trypsin
cleavag
site
also
requir
protein
cleavag
cleavag
fragment
produc
trypsin
differ
decor
nglycan
suggest
proteas
cleav
differ
sar
glycoform
although
requir
sar
cleavag
residu
dispens
protein
activ
convers
residu
previous
report
requir
sar
activ
trypsin
dispens
protein
cleavag
requir
protein
activ
collect
result
show
differ
residu
sar
control
cleavag
activ
suggest
process
complex
initi
appreci
open
access
citat
reink
lm
spiegel
plegg
hartleib
nehlmeier
gierer
et
al
differ
residu
sarscov
spike
protein
determin
cleavag
activ
host
cell
proteas
plo
one
http
subfamili
coronavirina
within
famili
coronavirida
compris
virus
caus
respiratori
neurolog
intestin
symptom
mammal
bird
sever
acut
respiratori
syndrom
coronaviru
sarscov
member
genu
betacoronaviru
emerg
southern
china
subsequ
spread
mainli
asia
wreck
massiv
econom
havoc
associ
almost
death
anoth
betacoronaviru
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
saudi
arabia
caus
sarslik
diseas
particularli
patient
underli
chronic
ill
indic
emerg
coronavirus
constitut
sever
threat
human
health
sarscov
spike
protein
sar
incorpor
viral
envelop
mediat
viral
entri
target
cell
surfac
unit
sar
bind
cellular
receptor
angiotensin
convert
enzym
transmembran
unit
fuse
viral
membran
host
cell
membran
activ
sar
cellular
proteas
prerequisit
membran
fusion
proteas
choic
determin
cellular
local
membran
fusion
occur
thu
bind
sarscov
trigger
uptak
virion
host
cell
endosom
phdepend
cystein
proteas
cathepsin
bl
cleav
activ
protein
altern
type
ii
transmembran
serin
proteas
cleav
sar
potenti
near
cell
surfac
render
sar
sdriven
entri
independ
cathepsin
bl
activ
cathepsin
bl
cleav
activ
sar
cell
line
activ
seem
requir
viral
spread
host
sinc
serin
proteas
inhibitor
activ
cystein
proteas
inhibitor
activ
cathepsin
bl
protect
rodent
sarscovinduc
pathogenesi
scenario
would
keep
find
express
requir
spread
sever
influenza
virus
fluav
mice
polymorph
impact
sever
influenza
human
patient
present
fulli
understood
site
sar
cleav
cellular
proteas
protein
activ
treatment
cellassoci
sar
sbear
particl
trypsin
frequent
use
substitut
protein
activ
cellular
proteas
allow
cathepsin
bl
independ
entri
sar
residu
essenti
process
similarli
human
airway
tryptas
hat
enzym
shown
cleav
sar
residu
found
critic
sar
activ
cellcel
fusion
locat
border
subunit
defin
cleavag
site
site
found
divers
coronaviru
protein
embed
differ
cleavag
motif
frequent
cleav
protein
biogenesi
moreov
role
sar
activ
trypsin
demonstr
residu
defin
cleavag
site
also
present
coronaviru
protein
believ
cleav
viral
entri
howev
cleavag
sar
site
could
visual
far
potenti
due
transient
natur
cleavag
product
basi
observ
twostep
mechan
sar
activ
propos
encompass
consecut
cleavag
sar
contrast
present
unknown
sar
cleav
protein
activ
although
suggest
hat
process
sar
differ
site
investig
residu
sar
requir
cleavag
activ
provid
evid
trypsin
produc
sar
fragment
ident
amino
acid
sequenc
differ
nglycan
decor
suggest
proteas
cleav
differ
sar
glycoform
site
keep
find
demonstr
requir
sar
cleavag
trypsin
dispens
convers
requir
activ
sar
express
plasmid
sar
wt
mutant
describ
previous
plasmid
encod
vesicular
stomat
viru
glycoprotein
vsvg
mlvbase
pseudotyp
system
also
describ
previous
plasmid
express
sar
mutant
gener
overlapextens
pcr
sar
construct
equip
ctermin
antigen
tag
insert
plasmid
pcagg
obtain
plasmid
encod
use
plasma
membran
marker
first
replac
egfp
gene
clontech
transfer
ntermin
codon
neuromodulin
gene
peyfpmem
clontech
plasmid
pegfpgolgi
encod
golgi
marker
fuse
gfp
describ
previous
integr
pcramplifi
sequenc
verifi
employ
autom
sequenc
analysi
human
embryon
kidney
cell
african
green
monkey
deriv
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
penicillin
streptomycin
humidifi
atmospher
contain
ident
cell
line
verifi
short
tandem
repeat
str
analysi
cell
obtain
collabor
cell
test
neg
mycoplasma
analysi
sar
cleavag
plasmid
encod
sar
empti
plasmid
transient
transfect
cell
employ
capo
method
h
post
transfect
cell
either
pb
treat
incub
trypsin
sigmaaldrich
st
loui
usa
min
lyse
x
sd
sampl
buffer
trishcl
glycerol
sd
betamercaptoethanol
bromphenolblu
mm
edta
min
cell
lysat
separ
sdspage
transfer
onto
nitrocellulos
membran
ge
healthcar
full
length
sar
protein
cleavag
fragment
thereof
contain
sar
cterminu
detect
stain
antibodi
novex
antimousehrp
dianova
secondari
antibodi
load
control
strip
membran
incub
antibodi
sigmaaldrich
antirabbithrp
dianova
secondari
antibodi
analysi
sar
modif
nlink
glycan
cell
transfect
express
sar
presenc
absenc
treat
trypsin
pellet
centrifug
rpm
min
pellet
solv
tne
buffer
mm
trishcl
nacl
mm
edta
incub
h
pngase
f
newengland
biolab
accord
manufactur
instruct
control
incub
absenc
enzym
subsequ
sampl
analyz
immunoblot
describ
immunohistochemistri
confoc
microscopi
cell
seed
glass
coverslip
plate
cell
per
well
hour
later
cell
capocotransfect
plasmid
encod
sar
wt
mutant
marker
protein
local
plasma
membran
ntermin
amino
acid
neuromodulin
fuse
yfp
golgi
apparatu
fuse
gfp
h
incub
cell
wash
twice
pb
fresh
cultur
medium
ad
h
post
transfect
cell
fix
stain
describ
elsewher
use
mous
monoclon
invitrogen
primari
antibodi
alexa
fluor
donkey
antimous
igg
invitrogen
secondari
antibodi
fluoresc
imag
acquir
color
confoc
laser
scan
microscop
lsm
pascal
axioskop
mot
plu
carl
zeiss
microimag
gmbh
use
zeiss
plan
apochromat
object
lsm
pascal
softwar
version
confoc
imag
convert
jpeg
format
use
softwar
axiovis
rel
carl
zeiss
microimag
gmbh
analysi
sar
activ
viruscel
fusion
retrovir
pseudotyp
employ
describ
previous
brief
pseudotyp
produc
transient
capotransfect
cell
plasmid
encod
mlvgagpol
luciferas
encod
mlv
vector
express
plasmid
sar
wt
mutant
cotransfect
plasmid
encod
vsvg
serv
posit
control
cotransfect
empti
plasmid
serv
neg
control
cultur
medium
replac
fresh
medium
h
harvest
h
posttransfect
supernat
filter
pores
filter
aliquot
store
incorpor
glycoprotein
mlv
particl
examin
immunoblot
mlv
capsid
protein
acri
sar
describ
concentr
pseudotyp
centrifug
sucros
cushion
transduct
experi
target
cell
seed
plate
transfect
plasmid
encod
andor
cultur
medium
replac
h
posttransfect
h
cell
reseed
plate
h
posttransfect
cell
incub
h
cathepsin
bl
inhibitor
sigmaaldrich
concentr
dmso
total
volum
per
well
subsequ
inhibitor
remov
per
well
pseudotyp
prepar
ad
triplic
well
h
thereaft
medium
dilut
h
post
transduct
cell
harvest
luciferas
activ
cell
lysat
measur
employ
commerci
avail
kit
pjk
accord
manufactur
instruct
onetail
student
ttest
use
examin
statist
signific
order
identifi
sar
residu
requir
protein
cleavag
activ
first
investig
cleavag
fragment
produc
upon
cotransfect
cell
constant
amount
sar
plasmid
decreas
amount
plasmid
sinc
express
low
amount
proteas
transfect
cell
may
best
reflect
express
lung
protein
antigen
tag
employ
studi
ctermin
protein
fragment
detect
western
blot
employ
antibodi
approach
reveal
product
sar
fragment
kda
fig
intens
kda
band
increas
upon
reduct
express
highest
signal
observ
upon
transfect
plasmid
fig
contrast
incub
sar
express
cell
trypsin
produc
kda
fragment
fig
keep
publish
data
next
investig
whether
differ
size
sar
cleavag
fragment
produc
trypsin
reflect
differ
amino
acid
sequenc
nglycosyl
statu
remov
nglycan
pngase
f
reveal
latter
case
untreat
sar
fragment
produc
upon
cleavag
trypsin
migrat
differ
speed
gel
migrat
ident
upon
pngase
f
treatment
fig
find
suggest
trypsin
cleav
sar
site
sar
isoform
exhibit
differenti
nglycosyl
cleav
order
identifi
cleavag
site
sar
mutat
residu
previous
report
requir
sar
cleavag
andor
activ
trypsin
moreov
mutat
order
investig
whether
potenti
cleavag
motif
locat
ntermin
involv
sar
cleavag
final
alter
residu
previous
suggest
requir
sar
activ
cathepsin
l
mutat
residu
locat
surfac
protein
trimer
access
proteas
unlik
obstruct
nglycan
potenti
except
fig
mutat
abrog
sar
process
kda
fragment
trypsin
kda
fragment
respect
fig
indic
enzym
cleav
sar
site
contrast
mutat
inhibit
sar
process
trypsin
modest
impact
protein
cleavag
fig
similar
observ
made
residu
fig
final
mutat
inhibit
sar
process
trypsin
compat
cleavag
fig
although
reduc
level
mutat
block
sar
cleavag
trypsin
fig
collect
result
indic
residu
requir
sar
process
trypsin
suggest
also
residu
ntermin
might
impact
proteolyt
process
sar
next
investig
whether
differenti
cellular
local
sar
mutant
might
account
differenti
process
trypsin
andor
immunofluoresc
transfect
cell
coexpress
sar
wt
mutant
jointli
yfp
target
plasma
membran
reveal
sar
wt
mutant
traffick
cell
surfac
although
intracellular
level
mutant
protein
slightli
mutant
markedli
higher
observ
wt
protein
fig
contrast
mutat
residu
result
intracellular
retent
mutant
protein
fig
order
character
intracellular
compart
mutant
accumul
repeat
experi
describ
includ
marker
golgi
local
instead
plasma
membran
marker
found
signal
detect
mutant
partial
overlap
golgi
signal
littl
overlap
detect
mutant
fig
howev
cell
detect
express
high
level
mutant
present
unclear
reason
result
suggest
mutat
may
render
sar
trypsinresist
preclud
normal
sar
traffick
constitut
secretori
pathway
requir
protein
exposur
proteas
similar
reason
might
account
resist
mutant
cleavag
trypsin
retrovir
particl
encod
firefli
luciferas
report
harbor
sar
envelop
pseudotyp
commonli
use
studi
sar
sdriven
host
cell
entri
sinc
sought
employ
pseudotyp
investig
proteolyt
activ
sar
mutant
next
determin
whether
mutat
studi
modul
sar
incorpor
retrovir
particl
particl
bud
plasma
membran
one
would
thu
expect
protein
express
appreci
level
cell
surfac
incorpor
particl
analysi
particl
prepar
reveal
robust
compar
signal
sar
wt
mutant
inspect
control
supernat
confirm
signal
mainli
due
particleassoci
protein
fig
mutant
detect
particl
well
although
reduc
level
compar
sar
wt
mutant
incorpor
particl
fig
keep
intracellular
accumul
fig
agreement
find
mutat
compat
particl
infect
fig
transduct
driven
protein
mutant
studi
roughli
compar
measur
sar
wt
least
cell
transfect
express
examin
fig
transduct
untransfect
control
cell
fig
known
express
endogen
low
level
gener
less
robust
transduct
cell
entri
driven
protein
mutant
reduc
compar
sar
wt
observ
suggest
mutat
interfer
normal
protein
traffick
incorpor
retrovir
particl
contrast
mutat
compat
protein
traffick
cell
surfac
particl
incorpor
proteindriven
entri
cell
express
high
level
final
assess
amino
acid
requir
sar
activ
cotransfect
target
cell
plasmid
either
empti
plasmid
tmp
plasmid
incub
cell
dmso
cathepsin
bl
inhibitor
mdl
addit
sar
sbear
particl
absenc
inhibitor
express
modestli
increas
cellular
entri
driven
sar
wt
mutant
fail
augment
entri
driven
mutant
incub
mdl
significantli
reduc
transduct
driven
sar
wt
compar
untreat
cell
effect
membran
anchor
red
color
stain
sar
antibodi
antimous
alexa
fluor
secondari
antibodi
green
color
cell
analyz
confoc
microscopi
similar
result
obtain
second
independ
experi
b
experi
carri
describ
panel
gfp
fuse
golgi
marker
red
color
use
instead
yfp
plasma
membran
anchor
result
confirm
second
separ
experi
optim
visual
color
manual
assign
lsm
pascal
softwar
version
correspond
actual
emiss
spectra
yfp
gfp
alexa
fluor
rescu
express
fig
expect
similar
result
obtain
mutant
resist
process
sar
trypsin
fig
contrast
entri
mediat
mutant
modestli
cell
transfect
express
mlv
particl
pseudotyp
sar
wt
indic
sar
mutant
correspond
supernat
analyz
express
protein
employ
antibodi
mlv
capsid
protein
employ
antibodi
western
blot
cell
transfect
express
protein
alon
transfect
empti
plasmid
use
control
similar
result
obtain
two
independ
experi
b
target
cell
transfect
empti
plasmid
control
plasmid
transduc
equal
volum
pseudotyp
bear
indic
viral
glycoprotein
transduct
effici
quantifi
measur
luciferas
activ
cell
lysat
result
normal
sar
sdriven
transduct
express
cell
set
averag
three
eight
independ
experi
shown
error
bar
indic
standard
error
mean
sem
significantli
block
mdl
blockad
rescu
upon
coexpress
fig
suggest
critic
sar
activ
thu
seem
requir
sar
cleavag
activ
revers
appli
residu
sever
recent
find
suggest
potenti
target
antivir
intervent
express
proteas
essenti
spread
sever
fluav
strain
mice
polymorph
increas
proteas
express
link
sever
influenza
human
serin
proteas
inhibitor
block
serin
proteas
protect
rodent
sarscov
pathogenesi
investig
determin
sar
control
cleavag
activ
residu
found
essenti
sar
cleavag
residu
dispens
target
cell
transfect
plasmid
cotransfect
plasmid
pretreat
dmso
cathepsin
bl
inhibitor
mdl
h
addit
equal
volum
pseudotyp
bear
indic
glycoprotein
cellular
entri
quantifi
measur
luciferas
activ
cell
lysat
result
normal
transduct
absenc
inhibitor
set
averag
three
six
independ
experi
shown
n
sar
wt
vsvg
n
n
error
bar
indic
sem
statist
signific
assess
use
onetail
student
test
http
protein
activ
convers
residu
impact
sar
cleavabl
essenti
viru
activ
proteas
follow
discuss
provid
potenti
explan
first
sight
paradox
find
previous
document
coexpress
high
amount
sar
result
product
sever
ctermin
cleavag
fragment
contrast
singl
promin
cleavag
product
observ
present
studi
differ
due
choic
antibodi
use
sar
detect
initi
studi
employ
rabbit
serum
thu
detect
cleavag
fragment
harbor
antibodi
target
irrespect
presenc
sar
cterminu
contrast
antibodi
specif
ad
cterminu
sar
use
present
studi
thu
sar
fragment
intact
cterminu
detect
major
cleavag
product
observ
present
studi
exhibit
molecular
weight
kda
compris
entir
subunit
discuss
product
fragment
increas
express
decreas
suggest
fragment
might
major
cleavag
product
gener
physiolog
condit
ie
express
level
low
although
effect
could
partial
due
previous
document
cytotox
effect
observ
upon
direct
express
cell
two
point
consid
interpret
result
cleavag
analysi
first
condit
chosen
substanti
fraction
protein
secret
extracellular
space
due
cleavag
sar
membran
proxim
site
product
fragment
remain
undetect
present
studi
due
usag
antibodi
specif
ctermin
tag
discuss
like
account
rel
modest
intens
signal
observ
membran
associ
kda
sarss
fragment
second
employ
ci
set
sar
express
cell
studi
sar
cleavag
set
allow
readili
detect
product
sar
cleavag
fragment
reflect
sar
locat
differ
membran
ie
viral
cellular
membran
respect
viral
entri
moreov
need
consid
sar
might
associ
viral
membran
protein
context
sarscov
infect
absent
transfect
cell
examin
report
previous
trypsin
cleav
sar
differ
site
sinc
enzym
produc
differ
sar
cleavag
fragment
differ
size
sar
cleavag
product
gener
trypsin
also
observ
present
studi
trypsin
gener
kda
fragment
produc
kda
fragment
howev
enzymat
digest
reveal
kda
differ
molecular
weight
result
differenti
decor
fragment
nglycan
differ
amino
acid
chain
keep
find
mutat
inhibit
sar
cleavag
trypsin
indic
proteas
cleav
sar
contrast
find
discuss
publish
work
argu
role
sar
cleavag
employ
specif
antibodi
observ
two
promin
sar
cleavag
fragment
upon
coexpress
product
fragment
reduc
abrog
upon
mutat
sinc
reduct
modest
conclud
essenti
sar
process
light
find
present
studi
revis
conclus
previous
observ
reduc
product
protein
fragment
due
mutat
promin
effect
like
miss
higher
amount
express
previou
compar
present
studi
digest
sar
trypsin
gener
differenti
glycosyl
protein
fragment
result
indic
differenti
glycosyl
cleavag
product
might
reflect
differenti
cellular
local
correspond
cleavag
process
thu
trypsin
ad
cultur
medium
cleav
almost
exclus
sar
locat
cell
surfac
contrast
might
process
sar
earli
import
constitut
secretori
pathway
nglycan
fulli
process
scenario
support
find
mainli
local
within
cell
activ
fluav
hemagglutinin
occur
mainli
intracellularli
potenti
impact
cellular
local
sar
proteas
protein
process
also
reflect
mutant
mutant
unabl
fulli
travers
constitut
secretori
pathway
defect
compat
cleavag
within
cell
trypsin
cleavag
cell
surfac
whether
postul
process
sar
earli
travers
secretori
pathway
observ
context
sarscov
infect
human
respiratori
cell
due
overexpress
remain
determin
sar
activ
exhibit
trypsinlik
specif
trypsin
employ
substitut
action
proteas
previou
work
demonstr
trypsin
cleav
sar
present
studi
show
residu
critic
sar
process
requir
sar
cleavag
trypsin
translat
key
role
residu
sar
activ
viruscel
fusion
proteas
previou
studi
show
mutat
abrog
sar
activ
trypsin
present
work
demonstr
residu
dispens
sar
activ
convers
requir
sar
activ
trypsin
present
studi
although
residu
essenti
robust
protein
process
proteas
present
studi
least
ci
set
propos
cleavag
occur
tran
cleavag
fragment
could
detect
potenti
due
low
stabil
present
unclear
cleavag
activ
sar
trypsin
depend
residu
case
howev
find
entir
unexpect
belouzard
whittak
previous
suggest
sar
activ
might
requir
two
consecut
cleavag
one
one
also
found
residu
dispens
cathepsin
bldepend
sar
sdriven
endosom
entri
moreov
present
studi
show
neither
requir
sar
smediat
endosom
entri
evidenc
robust
transduct
untreat
cell
sar
mutant
fig
blockad
entri
mdl
fig
find
suggest
rel
low
sequenc
specif
cathepsin
bl
might
allow
sar
cleavageactiv
site
conceiv
employ
auxiliari
cleavag
site
cathepsin
bl
avail
identif
site
focu
futur
studi
collect
studi
show
sar
cleavag
activ
depend
differ
amino
acid
residu
work
requir
elucid
interplay
protein
activ
membran
fusion
structur
trimer
sar
amino
acid
residu
protein
structur
id
pmid
download
rcsb
protein
data
bank
analyz
use
yasara
softwar
wwwyasaraorg
pmid
sinc
deposit
molecul
contain
alanin
posit
manual
chang
arginin
next
molecular
surfac
sar
visual
specif
amino
acid
residu
highlight
follow
receptor
bind
domain
light
blue
asparagin
residu
within
nglycosyl
signal
blue
red
pink
green
yellow
b
individu
insert
singl
amino
acid
residu
investig
nglycosyl
signal
proxim
respect
amino
acid
residu
investig
highlight
white
arrowhead
doc
